Kinetics and Signal Activation Properties of Circulating Factor(s) From Healthy Volunteers Undergoing Remote Ischemic Pre-Conditioning

JACC: Basic to Translational Science

Volumn 1, Issue 1-2, 1970, Pages 132-140

  Hildebrandt, Heike A ^a   Kreienkamp, Vincent ^a   Gent, Sabine ^a   Kahlert, Philipp ^a   Heusch, Gerd ^a   Kleinbongard, Petra ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

cardioprotection; human; humoral factor; kinetics; remote ischemic pre conditioning; signaling

Indexed keywords

EID: 85057506118     PISSN: 2452302X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacbts.2016.01.007     Document Type: Article

References (48)

1. 1 Heusch, G., Bøtker, H.E., Przyklenk, K., Redington, A., Yellon, D., Remote ischemic conditioning. J Am Coll Cardiol 65 (2015), 177–195.
2. 2 Davies, W.R., Brown, A.J., Watson, W., et al. Remote ischemic preconditioning improves outcome at 6 years after elective percutaneous coronary intervention: the CRISP stent trial long-term follow-up. Circ Cardiovasc Interv 6 (2013), 246–251.
3. 3 Hausenloy, D.J., Mwamure, P.K., Venugopal, V., et al. Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial. Lancet 370 (2007), 575–579.
4. 4 Thielmann, M., Kottenberg, E., Kleinbongard, P., et al. Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single-centre randomised, double-blind, controlled trial. Lancet 382 (2013), 597–604.
5. 5 Candilio, L., Malik, A., Ariti, C., et al. Effect of remote ischaemic preconditioning on clinical outcomes in patients undergoing cardiac bypass surgery: a randomised controlled clinical trial. Heart 101 (2015), 185–192.
6. 6 Bøtker, H.E., Kharbanda, R., Schmidt, M.R., et al. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet 375 (2010), 727–734.
7. 7 Sloth, A.D., Schmidt, M.R., Munk, K., et al. Improved long-term clinical outcomes in patients with ST-elevation myocardial infarction undergoing remote ischaemic conditioning as an adjunct to primary percutaneous coronary intervention. Eur Heart J 35 (2014), 168–175.
8. 8 Eitel, I., Stiermaier, T., Rommel, K.P., et al. Cardioprotection by combined intrahospital remote ischaemic perconditioning and postconditioning in ST-elevation myocardial infarction: the randomized LIPSIA conditioning trial. Eur Heart J 36 (2015), 3049–3057.
9. 9 Yellon, D.M., Ackbarkhan, A.K., Balgobin, V., et al. Remote ischemic conditioning reduces myocardial infarct size in STEMI patients treated by thrombolysis. J Am Coll Cardiol 65 (2015), 2764–2765.
10. 10 White, S.K., Frohlich, G.M., Sado, D.M., et al. Remote ischemic conditioning reduces myocardial infarct size and edema in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol Intv 8 (2015), 178–188.
11. 11 Hausenloy, D.J., Candilio, L., Evans, R., et al. Remote ischemic preconditioning and outcomes of cardiac surgery. N Engl J Med 373 (2015), 1408–1417.
12. 12 Meybohm, P., Bein, B., Brosteanu, O., et al. A multicenter trial of remote ischemic preconditioning for heart surgery. N Engl J Med 373 (2015), 1397–1407.
13. 13 Ferdinandy, P., Hausenloy, D.J., Heusch, G., Baxter, G.F., Schulz, R., Interaction of risk factors, comorbidities, and comedications with ischemia/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning. Pharmacol Rev 66 (2014), 1142–1174.
14. 14 Heusch, G., Gersh, B.J., ERICCA and RIPHeart: two nails in the coffin for cardioprotection by remote ischemic conditioning? Probably not. Eur Heart J 37 (2016), 200–202.
15. 15 Kleinbongard, P., Neuhäuser, M., Thielmann, M., et al. Confounders of cardioprotection by remote ischemic preconditioning in patients undergoing coronary artery bypass grafting. Cardiology 133 (2016), 128–133.
16. 16 Kottenberg, E., Thielmann, M., Bergmann, L., et al. Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol - a clinical trial. Acta Anaesthesiol Scand 56 (2012), 30–38.
17. 17 Rassaf, T., Totzeck, M., Hendgen-Cotta, U.B., Shiva, S., Heusch, G., Kelm, M., Circulating nitrite contributes to cardioprotection by remote ischemic preconditioning. Circ Res 114 (2014), 1601–1610.
18. 18 Davidson, S.M., Selvaraj, P., He, D., et al. Remote ischaemic preconditioning involves signalling through the SDF-1α/CXCR4 signalling axis. Basic Res Cardiol, 108, 2013, 377.
19. 19 Li, J., Rohailla, S., Gelber, N., et al. MicroRNA-144 is a circulating effector of remote ischemic preconditioning. Basic Res Cardiol, 109, 2014, 423.
20. 20 Hepponstall, M., Ignjatovic, V., Binos, S., et al. Remote ischemic preconditioning (RIPC) modifies plasma proteome in humans. PLoS One, 7, 2012, e48284.
21. 21 Helgeland, E., Breivik, L.E., Vaudel, M., et al. Exploring the human plasma proteome for humoral mediators of remote ischemic preconditioning-a word of caution. PLoS One, 9, 2014, e109279.
22. 22 Cheung, M.M., Kharbanda, R.K., Konstantinov, I.E., et al. Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: first clinical application in humans. J Am Coll Cardiol 47 (2006), 2277–2282.
23. 23 Heinen, N.M., Pütz, V.E., Görgens, J.I., et al. Cardioprotection by remote ischemic preconditioning exhibits a signaling pattern different from local ischemic preconditioning. Shock 36 (2011), 45–53.
24. 24 Li, G., Labruto, F., Sirsjo, A., Chen, F., Vaage, J., Valen, G., Myocardial protection by remote preconditioning: the role of nuclear factor kappa-B p105 and inducible nitric oxide synthase. Eur J Cardiothorac Surg 26 (2004), 968–973.
25. 25 Zhou, W., Zeng, D., Chen, R., et al. Limb ischemic preconditioning reduces heart and lung injury after an open heart operation in infants. Pediatr Cardiol 31 (2010), 22–29.
26. 26 Wagner, R., Piler, P., Bedanova, H., Adamek, P., Grodecka, L., Freiberger, T., Myocardial injury is decreased by late remote ischaemic preconditioning and aggravated by tramadol in patients undergoing cardiac surgery: a randomised controlled trial. Interact Cardiovasc Thorac Surg 11 (2010), 758–762.
27. 27 Liu, Z., Wang, Y.L., Hua, Q., Chu, Y.Y., Ji, X.M., Late remote ischemic preconditioning provides benefit to patients undergoing elective percutaneous coronary intervention. Cell Biochem Biophys 70 (2014), 437–442.
28. 28 Manchurov, V., Ryazankina, N., Khmara, T., et al. Remote ischemic preconditioning and endothelial function in patients with acute myocardial infarction and primary PCI. Am J Med 127 (2014), 670–673.
29. 29 Heusch, G., Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning. Circ Res 116 (2015), 674–699.
30. 30 Skyschally, A., Gent, S., Amanakis, G., Schulte, C., Kleinbongard, P., Heusch, G., Across-species transfer of protection by remote ischemic preconditioning with species-specific myocardial signal transduction by reperfusion injury salvage kinase and survival activating factor enhancement pathways. Circ Res 117 (2015), 279–288.
31. 31 Yamaura, G., Turoczi, T., Yamamoto, F., Siddqui, M.A., Maulik, N., Das, D.K., STAT signaling in ischemic heart: a role of STAT5A in ischemic preconditioning. Am J Physiol Heart Circ Physiol 285 (2003), H476–H482.
32. 32 Suleman, N., Somers, S., Smith, R., Opie, L.H., Lecour, S.C., Dual activation of STAT-3 and Akt is required during the trigger phase of ischaemic preconditioning. Cardiovasc Res 79 (2008), 127–133.
33. 33 Lacerda, L., Somers, S., Opie, L.H., Lecour, S., Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway. Cardiovasc Res 84 (2009), 201–208.
34. 34 Somers, S.J., Frias, M., Lacerda, L., Opie, L.H., Lecour, S., Interplay between SAFE and RISK pathways in sphingosine-1-phosphate-induced cardioprotection. Cardiovasc Drugs Ther 26 (2012), 227–237.
35. 35 Boengler, K., Hilfiker-Kleiner, D., Heusch, G., Schulz, R., Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion. Basic Res Cardiol 105 (2010), 771–785.
36. 36 Heusch, G., Musiolik, J., Gedik, N., Skyschally, A., Mitochondrial STAT3 activation and cardioprotection by ischemic postconditioning in pigs with regional myocardial ischemia/reperfusion. Circ Res 109 (2011), 1302–1308.
37. 37 Konstantinov, I.E., Arab, S., Kharbanda, R.K., et al. The remote ischemic preconditioning stimulus modifies inflammatory gene expression in humans. Physiol Genomics 19 (2004), 143–150.
38. 38 Zitta, K., Meybohm, P., Bein, B., et al. Serum from patients undergoing remote ischemic preconditioning protects cultured human intestinal cells from hypoxia-induced damage: involvement of matrixmetalloproteinase-2 and -9. Mol Med 18 (2012), 29–37.
39. 39 Gonzalez, N.R., Hamilton, R., Bilgin-Freiert, A., et al. Cerebral hemodynamic and metabolic effects of remote ischemic preconditioning in patients with subarachnoid hemorrhage. Acta Neurochir Suppl 115 (2013), 193–198.
40. 40 Giricz, Z., Varga, Z.V., Baranyai, T., et al. Cardioprotection by remote ischemic preconditioning of the rat heart is mediated by extracellular vesicles. J Mol Cell Cardiol 68 (2014), 75–78.
41. 41 Smith, R.M., Suleman, N., Lacerda, L., et al. Genetic depletion of cardiac myocyte STAT-3 abolishes classical preconditioning. Cardiovasc Res 63 (2004), 611–616.
42. 42 Cai, Z.P., Parajuli, N., Zheng, X., Becker, L., Remote ischemic preconditioning confers late protection against myocardial ischemia-reperfusion injury in mice by upregulating interleukin-10. Basic Res Cardiol, 107, 2012, 277.
43. 43 Oba, T., Yasukawa, H., Nagata, T., et al. Renal nerve-mediated erythropoietin release confers cardioprotection during remote ischemic preconditioning. Circ J 79 (2015), 1557–1567.
44. 44 Heusch, G., Musiolik, J., Kottenberg, E., Peters, J., Jakob, H., Thielmann, M., STAT5 activation and cardioprotection by remote ischemic preconditioning in humans: short communication. Circ Res 110 (2012), 111–115.
45. 45 Boengler, K., Hilfiker-Kleiner, D., Drexler, H., Heusch, G., Schulz, R., The myocardial JAK/STAT pathway: from protection to failure. Pharmacol Ther 120 (2008), 172–185.
46. 46 Haghikia, A., Stapel, B., Hoch, M., Hilfiker-Kleiner, D., STAT3 and cardiac remodeling. Heart Fail Rev 16 (2011), 35–47.
47. 47 Cai, Z., Luo, W., Zhan, H., Semenza, G.L., Hypoxia-inducible factor 1 is required for remote ischemic preconditioning of the heart. Proc Natl Acad Sci U S A 110 (2013), 17462–17467.
48. 48 Nechemia-Arbely, Y., Khamaisi, M., Rosenberger, C., et al. In vivo evidence suggesting reciprocal renal hypoxia-inducible factor-1 upregulation and signal transducer and activator of transcription 3 activation in response to hypoxic and non-hypoxic stimuli. Clin Exp Pharmacol Physiol 40 (2013), 262–272.